Linfeng Xu
Jiangmen, 529020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Rhodium-copper cooperative catalysis for [4+2] annulation: synthesis of pyrroloquinolinedione derivatives.
Journal: Chemical communications (Cambridge, England)
Published: August 19, 2026
Drug-eluting bead TACE improves the efficacy of HAIC combined with molecular-targeted therapy and anti-PD-1 immunotherapy in large hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus: a multicenter retrospective cohort study.
Journal: BMC cancer
Published: June 11, 2026
Safety and Efficacy of TACE-HAIC Combined with Lenvatinib and PD-1 Inhibitors in Large Intermediate-Stage Hepatocellular Carcinoma: A Multi-Center Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: December 12, 2025
Combination of programmed death protein-1 inhibitor improves the efficacy of transarterial chemoembolization plus lenvatinib for unresectable intermediate-stage hepatocellular carcinoma: a real-world multi-center retrospective study.
Journal: European journal of radiology
Published: October 05, 2025
Post-transarterial chemoembolization hypoxia-induced HIF-1α/WNT/β-catenin signaling promotes hepatocellular carcinoma progression via programed death ligand 1 upregulation.
Journal: Clinical and experimental immunology
Published: March 24, 2025
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer.
Journal: International journal of biological sciences
Published: July 27, 2023
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer.
Journal: Nature communications
Published: October 19, 2021
Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer.
Journal: Journal of cancer research and therapeutics
Published: July 16, 2021
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.
Journal: Journal of hematology & oncology
Published: May 26, 2021
Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis.
Journal: Journal of gastrointestinal oncology
Published: May 25, 2021
Effectiveness and safety of irreversible electroporation for recurrent hepatocellular carcinoma ineligible for thermal ablation after surgery.
Journal: Journal of interventional medicine
Published: July 09, 2020
Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma.
Journal: Translational cancer research
Published: January 31, 2020
Last Updated: 09/26/2026